Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease

OBJECTIVE: Deposition of Aβ-containing plaques as evidenced by amyloid imaging and CSF Aβ42 is an early indicator of preclinical Alzheimer disease (AD). To better understand their relationship during the earliest preclinical stages, we investigated baseline CSF markers in cognitively normal individu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Neurol
Asıl Yazarlar: Vlassenko, Andrei G., McCue, Lena, Jasielec, Mateusz S, Su, Yi, Gordon, Brian A., Xiong, Chengjie, Holtzman, David M, Benzinger, Tammie LS, Morris, John C, Fagan, Anne M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016232/
https://ncbi.nlm.nih.gov/pubmed/27398953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24719
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller